You are logged on as Guest.
RegisterLoginShopping cart (Empty)
 United States

CX3CL1 (soluble) (human), (recombinant)

 
ALX-201-388-C010 10 µg 194.00 USD
 
ALX-201-388-C050 50 µg 547.00 USD
 

Product Specification

Concentration:0.5mg/ml
 
Endotoxin Content:<0.1EU/µg protein (LAL-test).
 
Purity:≥90% (SDS-PAGE)
 
Formulation:Liquid. 0.2µm-filtered solution in PBS.
 
Biological Activity:Chemotaxis effect of soluble recombinant human CX3CL1 (fractalkine) in THP-1 cells (see Figure 2).
 
Source/Host:Produced in HEK 293 cells. Signal peptide and extracellular domain of human CX3CL1 (fractalkine) (aa 1-339) is fused at the C-terminus to a FLAG®-tag.
 
Long Term Storage:-20°C
 
Use/Stability:Working aliquots are stable for up to 3 months when stored at -20°C.
 
Handling:After opening, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
 
Background / Technical Information:UniProt ID P78423: Fractalkine (human)
FLAG is a registered trademark of Sigma-Aldrich Co.
 
201-388 sds
Figure 1: SDS-PAGE of CX3CL1, Soluble (human) (rec.) (Prod. No. ALX-201-388).
201-388
Figure 2: Chemotaxis effect of human CX3CL1, Soluble (human) (rec.) (Prod. No. ALX-201-388) in THP-1 cells. Method: Cell migration of THP-1 monocytic leukemia cells was evaluated in disposable 24-well transwell polystyrene membrane with 8µm pores. 100ng, 500ng, 1’000ng, 2’500ng and 5’000ng of human CX3CL1 were diluted in RPMI 1640 supplemented with 10mg/ml BSA respectively. CX3CL1 samples were added to the lower chamber. THP-1 cells(0.5x106 cells per well), in the same media with CX3CL1, Soluble (human) (rec.) were added to the upper chamber. After 2 hour incubation at 37°C in 5% CO2 humidified atmosphere, migration cells in the lower chamber were counted. Migrated cells in two separate fields per well from duplicate wells were enumerated on a hemacytometer by light microscopy.
Please mouse over
201-388 sds 201-388
©2010 Enzo Life Sciences, Inc.,